183 related articles for article (PubMed ID: 18322953)
1. Liver histology in ICU patients dying from sepsis: a clinico-pathological study.
Koskinas J; Gomatos IP; Tiniakos DG; Memos N; Boutsikou M; Garatzioti A; Archimandritis A; Betrosian A
World J Gastroenterol; 2008 Mar; 14(9):1389-93. PubMed ID: 18322953
[TBL] [Abstract][Full Text] [Related]
2. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
Kleiner DE; Chalasani NP; Lee WM; Fontana RJ; Bonkovsky HL; Watkins PB; Hayashi PH; Davern TJ; Navarro V; Reddy R; Talwalkar JA; Stolz A; Gu J; Barnhart H; Hoofnagle JH;
Hepatology; 2014 Feb; 59(2):661-70. PubMed ID: 24037963
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.
Dhingra S; Mahadik JD; Tarabishy Y; May SB; Vierling JM
Pathology; 2022 Oct; 54(6):686-693. PubMed ID: 35525796
[TBL] [Abstract][Full Text] [Related]
4. Steatosis and fibrosis in patients with chronic hepatitis C.
Wyatt J; Baker H; Prasad P; Gong YY; Millson C
J Clin Pathol; 2004 Apr; 57(4):402-6. PubMed ID: 15047745
[TBL] [Abstract][Full Text] [Related]
5. Are parenchymal changes in early post-transplant biopsies related to preservation-reperfusion injury or rejection?
Neil DA; Hubscher SG
Transplantation; 2001 Jun; 71(11):1566-72. PubMed ID: 11435966
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.
Zaitoun AM; Al Mardini H; Awad S; Ukabam S; Makadisi S; Record CO
J Clin Pathol; 2001 Jun; 54(6):461-5. PubMed ID: 11376020
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
[TBL] [Abstract][Full Text] [Related]
8. Histological features of chronic hepatitis C in haemodialysis patients.
Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
[TBL] [Abstract][Full Text] [Related]
9. Liver Histology in Septic Patients: Is It All About Ductular Cholestasis?
Bsirini C; Katerji R; Lee EJ; Gonzalez RS
Arch Pathol Lab Med; 2022 Nov; 146(11):1329-1337. PubMed ID: 35196387
[TBL] [Abstract][Full Text] [Related]
10. Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.
Esposito I; Kubisova A; Stiehl A; Kulaksiz H; Schirmacher P
Virchows Arch; 2008 Oct; 453(4):339-45. PubMed ID: 18769938
[TBL] [Abstract][Full Text] [Related]
11. Hepatic parenchymal changes and histologic eosinophilia as predictors of subsequent acute liver allograft rejection.
Demirhan B; Bilezikçi B; Haberal AN; Sevmiş S; Arat Z; Haberal M
Liver Transpl; 2008 Feb; 14(2):214-9. PubMed ID: 18236397
[TBL] [Abstract][Full Text] [Related]
12. [Light-microscopy demonstration of HB-Ag in liver biopsies. Comparative studies on HB-Ag findings in the serum with results of aldehyde-thionine staining].
Vogel HM; Henning H; Lüders CJ; von Braun HH; Tripatzis I
Z Gastroenterol; 1974 Jun; 12(4):257-64. PubMed ID: 4139830
[No Abstract] [Full Text] [Related]
13. Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model.
Wong VS; Wight DG; Palmer CR; Alexander GJ
J Clin Pathol; 1996 Jun; 49(6):465-9. PubMed ID: 8763259
[TBL] [Abstract][Full Text] [Related]
14. Resolution of nonalcoholic steatohepatits after gastric bypass surgery.
Liu X; Lazenby AJ; Clements RH; Jhala N; Abrams GA
Obes Surg; 2007 Apr; 17(4):486-92. PubMed ID: 17608261
[TBL] [Abstract][Full Text] [Related]
15. Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Ratziu V; Charlotte F; Heurtier A; Gombert S; Giral P; Bruckert E; Grimaldi A; Capron F; Poynard T;
Gastroenterology; 2005 Jun; 128(7):1898-906. PubMed ID: 15940625
[TBL] [Abstract][Full Text] [Related]
16. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
Brunt EM; Kleiner DE; Wilson LA; Unalp A; Behling CE; Lavine JE; Neuschwander-Tetri BA;
Hepatology; 2009 Mar; 49(3):809-20. PubMed ID: 19142989
[TBL] [Abstract][Full Text] [Related]
17. [Histomorphology of the liver by damage with phenolisatine-containing laxatives (Recurrent chronic cholangiohepatitis)].
Lüders CJ; Riske WE; Henning H; Vogel HM
Virchows Arch A Pathol Anat Histol; 1975; 365(4):309-25. PubMed ID: 803737
[TBL] [Abstract][Full Text] [Related]
18. Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.
Álvaro-Meca A; Jiménez-Sousa MA; Boyer A; Medrano J; Reulen H; Kneib T; Resino S
BMC Infect Dis; 2016 Mar; 16():122. PubMed ID: 26979964
[TBL] [Abstract][Full Text] [Related]
19. Sepsis in end-stage renal disease patients: are they at an increased risk of mortality?
Bou Chebl R; Tamim H; Abou Dagher G; Sadat M; Ghamdi G; Itani A; Saeedi A; Arabi YM
Ann Med; 2021 Dec; 53(1):1737-1743. PubMed ID: 34632897
[TBL] [Abstract][Full Text] [Related]
20. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis].
Piñol V; Bessa X; Bruguera M; Rodés J
Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
